Researchers unveil a groundbreaking hydrogel that mimics human skin's ability to heal itself rapidly, revolutionising ...

“Entanglement means that the thin polymer layers start to twist around each other like tiny wool yarns, but in a random order ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

Scientists have created a self-healing hydrogel that mimics human skin, offering a breakthrough solution for complete wound ...

Researchers have created a unique hydrogel that’s both tough and self-healing, thanks to nanosheet-enhanced polymer entanglement. The material repairs itself in hours and could revolutionize ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

Surgical adhesions—common, sometimes life-threatening complications that arise after open or laparoscopic abdominal ...

We all encounter gels in daily life – from the soft, sticky substances you put in your hair, to the jelly-like components in ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

The gel is designed to be a 'safe' debrider ... for factors that may influence debridement as well as healing of the wound. This will precede the confirmatory Phase III trials necessary for ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology ...